| Bioactivity | LysRs-IN-3 (compound 36) is an inhibitor of Plasmodium lysine tRNA synthetase based on ASP3026 (HY-13326), which has a more than seven-fold higher inhibitory effect on the growth of Plasmodium, especially Plasmodium falciparum, than ASP3026 (HY-13326). LysRs-IN-3 can be used in the development of antimalarial drugs[1]. |
| CAS | 2841466-02-0 |
| Formula | C20H23N5O4S |
| Molar Mass | 429.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhou J, et al. Structure-guided conversion from an anaplastic lymphoma kinase inhibitor into Plasmodium lysyl-tRNA synthetase selective inhibitors[J]. Communications Biology, 2024, 7(1): 742. |
LysRs-IN-3
CAS: 2841466-02-0 F: C20H23N5O4S W: 429.49
LysRs-IN-3 (compound 36) is an inhibitor of Plasmodium lysine tRNA synthetase based on ASP3026 (HY-13326), which has a m
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.